Direct-To-Consumer Teledermatology For Male Androgenetic Alopecia: Narrative Review

    September 2025 in “ JMIR Dermatology ”
    Finn Abeck, Inga Hansen-Abeck, Julian Kött … Johannes von Büren
    Studysummary This narrative review reported that direct-to-consumer teledermatology improves access to care, adherence, and patient satisfaction for treating male androgenetic alopecia, but may lead to higher drug costs.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on derma.jmir.org →
    Discuss this study in the Community →

    Research cited in this study 9

    1. Cross-Sectional Cost Analysis of Finasteride for Androgenetic Alopecia via Direct-to-Consumer Pharmacies Compared to Online Wholesale Pharmacies Journal of the American Academy of Dermatology · 2024
    2. Direct-To-Consumer Androgenetic Alopecia Treatments: A Cost Comparison With Traditional Pharmacies Journal of the American Academy of Dermatology · 2024
    3. Patient-Reported Outcomes of Topical Finasteride/Minoxidil Treatment for Male Androgenetic Alopecia: A Retrospective Study Using Telemedical Data Journal of cosmetic dermatology · 2024
    4. Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia Clinical, Cosmetic and Investigational Dermatology · 2023
    5. Patient-Reported Outcomes and Safety of Direct-to-Consumer Teledermatology for Finasteride in Male Androgenetic Alopecia DIGITAL HEALTH · 2023
    6. Digital Health Platforms Expand Access and Improve Care for Male Androgenetic Alopecia International Journal of Dermatology · 2022
    7. Telemedical Care of Men With Androgenetic Alopecia Demonstrates Improved Access to Care and Patient Benefit Journal of The European Academy of Dermatology and Venereology · 2022
    8. Efficacy and Safety of Topical Finasteride Spray Solution for Male Androgenetic Alopecia: A Phase III, Randomized, Controlled Clinical Trial Journal of The European Academy of Dermatology and Venereology · 2021
    9. Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version Journal of The European Academy of Dermatology and Venereology · 2017